Expression of concern to “Post-treatment with Resolvin D1 attenuates pulmonary hypertension by inhibiting endothelial-to-mesenchymal transition” [Biomed. Pharmacother. 177 (2024) 117023] - 17/04/26
Doi : 10.1016/j.biopha.2026.119313
Xinyu Li a, b, c, Hui Li a, b, c, Bo Feng a, b, c, Xiaoyan Chen d, Ting Chen a, b, c, Jiafei Lu a, b, c, Huating Xie a, b, c, Nana Su a, b, c, Houlin Chen a, b, c, Chenghao Lou a, b, c, Runxin Zhuang b, c, Xi Chen a, b, c, Shengwei Jin a, b, c, ⁎ 
, Yu Hao a, b, c, e, ⁎
, Yu Hao a, b, c, e, ⁎ a Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 325000, China
b Key Laboratory of Pediatric Anesthesiology, Ministry of Education, Wenzhou Medical University, Wenzhou 325000, China
c Key Laboratory of Anesthesiology of Zhejiang Province, Wenzhou Medical University, Wenzhou 325000, China
d Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
e Wenzhou Key Laboratory of Precision General Practice and Health Management, Wenzhou 325000, China
⁎ Corresponding authors at: Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 325000, China. Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University Wenzhou 325000 China
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Friday 17 April 2026
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?